> top > docs > PubMed:24398691 > annotations

PubMed:24398691 JSONTXT

Annnotations TAB JSON ListView MergeView

CL-cell

Id Subject Object Predicate Lexical cue cl_id
T1 1156-1169 Cell denotes keratinocytes http://purl.obolibrary.org/obo/CL:0000312
T2 1513-1526 Cell denotes keratinocytes http://purl.obolibrary.org/obo/CL:0000312

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 230-238 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T3 410-418 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T5 519-538 Glycan_Motif denotes N-acetylglucosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP
T6 596-604 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T8 698-717 Glycan_Motif denotes N-acetylglucosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP
T9 781-789 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T11 888-896 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T13 1099-1107 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T15 1198-1206 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T17 1318-1326 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO
T19 1595-1603 Glycan_Motif denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO

Glycosmos6-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 230-238 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T2 410-418 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 596-604 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T4 781-789 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T5 888-896 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T6 1099-1107 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T7 1198-1206 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T8 1318-1326 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T9 1595-1603 GlycoEpitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004

sentences

Id Subject Object Predicate Lexical cue
T1 0-81 Sentence denotes Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
T2 82-139 Sentence denotes Non-healing wounds are a significant source of morbidity.
T3 140-229 Sentence denotes This is particularly true for diabetic patients, who tend to develop chronic skin wounds.
T4 230-487 Sentence denotes O-GlcNAc modification of serine and threonine residues is a common regulatory post-translational modification analogous to protein phosphorylation; increased intracellular protein O-GlcNAc modification has been observed in diabetic and hyperglycemic states.
T5 488-765 Sentence denotes Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide β-N-acetylglucosaminyl transferase (OGT) and O-GlcNAc-selective N-acetyl-β-D-glucosaminidase (OGA), mediate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein substrates.
T6 766-1049 Sentence denotes Alterations in O-GlcNAc modification of intracellular proteins is linked to diabetes, and the increased levels of protein O-GlcNAc modification observed in diabetic tissues may in part explain some of the observed underlying pathophysiology that contributes to delayed wound healing.
T7 1050-1250 Sentence denotes We have previously shown that increasing protein O-GlcNAc modification by overexpression of OGT in murine keratinocytes results in elevated protein O-GlcNAc modification and a hyperadhesive phenotype.
T8 1251-1471 Sentence denotes This study was undertaken to explore the hypothesis that increased O-GlcNAc modification of cellular proteins in diabetic skin could contribute to the delayed wound healing observed in patients with diabetic skin ulcers.
T9 1472-1674 Sentence denotes In the present study, we show that human keratinocytes cultured under hyperglycemic conditions display increased levels of O-GlcNAc modification as well as a delay in the rate of wound closure in vitro.
T10 1675-1879 Sentence denotes We further show that specific knockdown of OGT by RNA interference (RNAi) reverses this effect, thereby opening up the opportunity for OGT-targeted therapies to promote wound healing in diabetic patients.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 230-238 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T2 230-238 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T3 410-418 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T4 410-418 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T5 519-538 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetylglucosamine
T6 596-604 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T7 596-604 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T8 698-717 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetylglucosamine
T9 781-789 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T10 781-789 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T11 888-896 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T12 888-896 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T13 1099-1107 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T14 1099-1107 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T15 1198-1206 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T16 1198-1206 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T17 1318-1326 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T18 1318-1326 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc
T19 1595-1603 https://glytoucan.org/Structures/Glycans/G49108TO denotes O-GlcNAc
T20 1595-1603 https://glytoucan.org/Structures/Glycans/G89565QL denotes O-GlcNAc

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 69-73 http://purl.obolibrary.org/obo/MAT_0000284 denotes skin
T2 217-221 http://purl.obolibrary.org/obo/MAT_0000284 denotes skin
T3 1373-1377 http://purl.obolibrary.org/obo/MAT_0000284 denotes skin
T4 1459-1463 http://purl.obolibrary.org/obo/MAT_0000284 denotes skin

DisGeNET

Id Subject Object Predicate Lexical cue
T0 888-896 gene:8473 denotes O-GlcNAc
T1 842-850 disease:C0011849 denotes diabetes
T2 781-789 gene:8473 denotes O-GlcNAc
T3 842-850 disease:C0011847 denotes diabetes
T4 888-896 gene:8473 denotes O-GlcNAc
T5 842-850 disease:C0011847 denotes diabetes
T6 781-789 gene:8473 denotes O-GlcNAc
T7 842-850 disease:C0011849 denotes diabetes
T8 1318-1326 gene:8473 denotes O-GlcNAc
T9 1459-1470 disease:C0037299 denotes skin ulcers
R1 T0 T1 associated_with O-GlcNAc,diabetes
R2 T2 T3 associated_with O-GlcNAc,diabetes
R3 T4 T5 associated_with O-GlcNAc,diabetes
R4 T6 T7 associated_with O-GlcNAc,diabetes
R5 T8 T9 associated_with O-GlcNAc,skin ulcers

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 466-479 HP_0003074 denotes hyperglycemic
T2 1459-1470 HP_0200042 denotes skin ulcers
T3 1542-1555 HP_0003074 denotes hyperglycemic

Allie

Id Subject Object Predicate Lexical cue
SS1_24398691_0_0 410-585 expanded denotes O-GlcNAc modification has been observed in diabetic and hyperglycemic states. Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide β-N-acetylglucosaminyl transferase
SS2_24398691_0_0 587-590 abbr denotes OGT
SS1_24398691_4_0 596-643 expanded denotes O-GlcNAc-selective N-acetyl-β-D-glucosaminidase
SS2_24398691_4_0 645-648 abbr denotes OGA
SS1_24398691_9_0 1725-1741 expanded denotes RNA interference
SS2_24398691_9_0 1743-1747 abbr denotes RNAi
AE1_24398691_0_0 SS1_24398691_0_0 SS2_24398691_0_0 abbreviatedTo "O-GlcNAc modification has been observed in diabetic and hyperglycemic states. Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide β-N-acetylglucosaminyl transferase",OGT
AE1_24398691_4_0 SS1_24398691_4_0 SS2_24398691_4_0 abbreviatedTo O-GlcNAc-selective N-acetyl-β-D-glucosaminidase,OGA
AE1_24398691_9_0 SS1_24398691_9_0 SS2_24398691_9_0 abbreviatedTo RNA interference,RNAi

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
24398691-5#15#23#gene8473 781-789 gene8473 denotes O-GlcNAc
24398691-5#76#84#diseaseC0011847 842-850 diseaseC0011847 denotes diabetes
24398691-5#76#84#diseaseC0011849 842-850 diseaseC0011849 denotes diabetes
24398691-7#67#75#gene8473 1318-1326 gene8473 denotes O-GlcNAc
24398691-7#208#219#diseaseC0037299 1459-1470 diseaseC0037299 denotes skin ulcers
15#23#gene847376#84#diseaseC0011847 24398691-5#15#23#gene8473 24398691-5#76#84#diseaseC0011847 associated_with O-GlcNAc,diabetes
15#23#gene847376#84#diseaseC0011849 24398691-5#15#23#gene8473 24398691-5#76#84#diseaseC0011849 associated_with O-GlcNAc,diabetes
67#75#gene8473208#219#diseaseC0037299 24398691-7#67#75#gene8473 24398691-7#208#219#diseaseC0037299 associated_with O-GlcNAc,skin ulcers

NGLY1-deficiency

Id Subject Object Predicate Lexical cue
PD-NGLY1-deficiency-B_T1 232-238 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T2 412-418 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T3 519-538 chem:24139 denotes N-acetylglucosamine
PD-NGLY1-deficiency-B_T4 553-573 chem:24139 denotes N-acetylglucosaminyl
PD-NGLY1-deficiency-B_T5 598-604 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T6 698-717 chem:24139 denotes N-acetylglucosamine
PD-NGLY1-deficiency-B_T7 719-725 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T8 783-789 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T9 890-896 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T10 1101-1107 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T11 1200-1206 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T12 1320-1326 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T13 1597-1603 chem:24139 denotes GlcNAc

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 74-80 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T2 94-100 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T3 222-228 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T4 842-850 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T5 1035-1040 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T6 1410-1415 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T7 1464-1470 Disease denotes ulcers http://purl.obolibrary.org/obo/MONDO_0043839
T8 1651-1656 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T9 1844-1849 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 69-80 Phenotype denotes skin wounds HP:0032674
T2 217-228 Phenotype denotes skin wounds HP:0032674
T3 1459-1470 Phenotype denotes skin ulcers HP:0200042

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 230-238 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T2 410-418 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T3 596-604 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T4 781-789 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T5 888-896 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T6 1099-1107 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T7 1198-1206 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T8 1318-1326 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T9 1595-1603 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 230-238 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T2 410-418 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 596-604 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T4 781-789 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T5 888-896 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T6 1099-1107 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T7 1198-1206 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T8 1318-1326 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T9 1595-1603 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 69-80 Phenotype denotes skin wounds HP:0032674
T2 217-228 Phenotype denotes skin wounds HP:0032674
T3 1459-1470 Phenotype denotes skin ulcers HP:0200042

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 74-80 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T2 94-100 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T3 222-228 Disease denotes wounds http://purl.obolibrary.org/obo/MONDO_0021178
T4 842-850 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T5 1035-1040 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T6 1410-1415 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T7 1464-1470 Disease denotes ulcers http://purl.obolibrary.org/obo/MONDO_0043839
T8 1651-1656 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178
T9 1844-1849 Disease denotes wound http://purl.obolibrary.org/obo/MONDO_0021178

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 1507-1512 OrganismTaxon denotes human 9606

GlyCosmos15-CL

Id Subject Object Predicate Lexical cue cl_id
T1 1156-1169 Cell denotes keratinocytes http://purl.obolibrary.org/obo/CL:0000312
T2 1513-1526 Cell denotes keratinocytes http://purl.obolibrary.org/obo/CL:0000312

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 69-73 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T5 217-221 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T9 388-401 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T10 492-505 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T11 732-745 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T12 806-819 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T13 1156-1169 Body_part denotes keratinocytes http://purl.obolibrary.org/obo/CL_0000312
T14 1373-1377 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T18 1459-1463 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T22 1513-1526 Body_part denotes keratinocytes http://purl.obolibrary.org/obo/CL_0000312
T23 1779-1786 Body_part denotes opening http://purl.obolibrary.org/obo/UBERON_0004111

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 69-73 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T2 217-221 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T3 1373-1377 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T4 1459-1463 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284

sentences

Id Subject Object Predicate Lexical cue
T1 0-81 Sentence denotes Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
T2 82-139 Sentence denotes Non-healing wounds are a significant source of morbidity.
T3 140-229 Sentence denotes This is particularly true for diabetic patients, who tend to develop chronic skin wounds.
T4 230-487 Sentence denotes O-GlcNAc modification of serine and threonine residues is a common regulatory post-translational modification analogous to protein phosphorylation; increased intracellular protein O-GlcNAc modification has been observed in diabetic and hyperglycemic states.
T5 488-765 Sentence denotes Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide β-N-acetylglucosaminyl transferase (OGT) and O-GlcNAc-selective N-acetyl-β-D-glucosaminidase (OGA), mediate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein substrates.
T6 766-1049 Sentence denotes Alterations in O-GlcNAc modification of intracellular proteins is linked to diabetes, and the increased levels of protein O-GlcNAc modification observed in diabetic tissues may in part explain some of the observed underlying pathophysiology that contributes to delayed wound healing.
T7 1050-1250 Sentence denotes We have previously shown that increasing protein O-GlcNAc modification by overexpression of OGT in murine keratinocytes results in elevated protein O-GlcNAc modification and a hyperadhesive phenotype.
T8 1251-1471 Sentence denotes This study was undertaken to explore the hypothesis that increased O-GlcNAc modification of cellular proteins in diabetic skin could contribute to the delayed wound healing observed in patients with diabetic skin ulcers.
T9 1472-1674 Sentence denotes In the present study, we show that human keratinocytes cultured under hyperglycemic conditions display increased levels of O-GlcNAc modification as well as a delay in the rate of wound closure in vitro.
T10 1675-1879 Sentence denotes We further show that specific knockdown of OGT by RNA interference (RNAi) reverses this effect, thereby opening up the opportunity for OGT-targeted therapies to promote wound healing in diabetic patients.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-81 Sentence denotes Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
T2 82-139 Sentence denotes Non-healing wounds are a significant source of morbidity.
T3 140-229 Sentence denotes This is particularly true for diabetic patients, who tend to develop chronic skin wounds.
T4 230-487 Sentence denotes O-GlcNAc modification of serine and threonine residues is a common regulatory post-translational modification analogous to protein phosphorylation; increased intracellular protein O-GlcNAc modification has been observed in diabetic and hyperglycemic states.
T5 488-765 Sentence denotes Two intracellular enzymes, UDP-N-acetylglucosamine-polypeptide β-N-acetylglucosaminyl transferase (OGT) and O-GlcNAc-selective N-acetyl-β-D-glucosaminidase (OGA), mediate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein substrates.
T6 766-1049 Sentence denotes Alterations in O-GlcNAc modification of intracellular proteins is linked to diabetes, and the increased levels of protein O-GlcNAc modification observed in diabetic tissues may in part explain some of the observed underlying pathophysiology that contributes to delayed wound healing.
T7 1050-1250 Sentence denotes We have previously shown that increasing protein O-GlcNAc modification by overexpression of OGT in murine keratinocytes results in elevated protein O-GlcNAc modification and a hyperadhesive phenotype.
T8 1251-1471 Sentence denotes This study was undertaken to explore the hypothesis that increased O-GlcNAc modification of cellular proteins in diabetic skin could contribute to the delayed wound healing observed in patients with diabetic skin ulcers.
T9 1472-1674 Sentence denotes In the present study, we show that human keratinocytes cultured under hyperglycemic conditions display increased levels of O-GlcNAc modification as well as a delay in the rate of wound closure in vitro.
T10 1675-1879 Sentence denotes We further show that specific knockdown of OGT by RNA interference (RNAi) reverses this effect, thereby opening up the opportunity for OGT-targeted therapies to promote wound healing in diabetic patients.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 230-238 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T2 410-418 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T3 596-604 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T4 781-789 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T5 888-896 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T6 1099-1107 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T7 1198-1206 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T8 1318-1326 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO
T9 1595-1603 Glycan denotes O-GlcNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G49108TO

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 230-238 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T2 410-418 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T3 596-604 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T4 781-789 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T5 888-896 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T6 1099-1107 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T7 1198-1206 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T8 1318-1326 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004
T9 1595-1603 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes O-GlcNAc http://www.glycoepitope.jp/epitopes/EP0004

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 1507-1512 OrganismTaxon denotes human 9606

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 69-73 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T2 217-221 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T3 1373-1377 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284
T4 1459-1463 Body_part denotes skin http://purl.obolibrary.org/obo/MAT_0000284

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 69-73 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T5 217-221 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T9 388-401 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T10 492-505 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T11 732-745 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T12 806-819 Body_part denotes intracellular http://purl.obolibrary.org/obo/GO_0005622
T13 1156-1169 Body_part denotes keratinocytes http://purl.obolibrary.org/obo/CL_0000312
T14 1373-1377 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T18 1459-1463 Body_part denotes skin http://purl.obolibrary.org/obo/UBERON_0000014|http://purl.obolibrary.org/obo/UBERON_0001003|http://purl.obolibrary.org/obo/UBERON_0002097|http://purl.obolibrary.org/obo/UBERON_0002199
T22 1513-1526 Body_part denotes keratinocytes http://purl.obolibrary.org/obo/CL_0000312
T23 1779-1786 Body_part denotes opening http://purl.obolibrary.org/obo/UBERON_0004111